Effectivity and safety profile of tenapanor, a sodium-hydrogen exchanger isoform 3 inhibitor, as an innovative treatment for hyperphosphatemia in chronic kidney disease: A systematic review of clinical studies William Suciangto; Haerani Rasyid; Anastasya Angelica Vicente; Winny Suciangto;

From stage 1 to end-stage renal failure: Amyloid ß42, amyloid ß40, amyloid ß42/40 ratio, p-tau181 and cognitive function relationship Yasemin Co¿kun Yavuz; Zeynep Biyik; Firdevs Sak; Muslu Kaz¿m Korez; Sedat Abusoglu; Lutfullah Altintepe;

Recomendaciones para la evaluación y tratamiento del paciente con diabetes y albuminuria. Papel del antagonismo mineralocorticoide no esteroideo Juan Payán López; Pedro Chinchurreta Capote; Antonio Hormigo Pozo; Luis Castilla-Guerra; José Carlos Fernández-García; Rosa Fernández Olmo; María José Espigares Huete;